Document is current

Article History

Received: 10 February 2025

Accepted: 19 May 2025

First Online: 21 May 2025

Declarations

:

: Yavor Yalachkov has been supported by travel grants from Alexion, Novartis and SanofiGenzyme and has received honoraria for active participation in advisory boards andspeaker/writing honoraria by Alexion, Amgen, Bristol Meyers Squibb, KassenärztlicheVereinigung Hessen, Landesärztekammer Hessen, Merck, Neuraxpharm, Novartis, RG Gesellschaft fürInformation und Organization mbH, Roche, Sanofi Genzyme, TEVA; his research is funded byDeutsche Forschungsgemeinschaft (DFG), Fachbereich Medizin der Goethe-UniversitätFrankfurt, Heinrich und Erna Schaufler Stiftung and Novartis. Kimberly Koerbel is a participantat the Junior Clinician Scientist Program funded by Goethe University Frankfurt and receivedspeaker honoraria by Novartis. Johannes Gehrig has been supported by a travel grant fromSanofi. Marion Hug reports no conflicts of interest. Iris‐Katharina Penner has receivedhonoraria for speaking at scientific meetings, serving at scientific advisory boards andconsulting activities from Adamas Pharma, Almirall, Bayer Pharma, Biogen, BMS, Celgene, Sanofi‐Genzyme, Janssen, Merck Serono GmbH (an affiliate of Merck KGaA), Novartis, Roche and Teva; she has received research support from the German MS Society, Celgene, Roche, Teva and Novartis. Michelle Maiworm received speaking honoraria from Roche, Synlab and Novartis; her research was funded by the Faculty of Medicine at the GoetheUniversity Frankfurt and the Goethe Research Academy for Early Career Researchers (GRADE) of the Goethe University Frankfurt, the Heinrich und Erna Schaufler-Foundation aswell as the MS Foundation of the State of Hesse.